|
MAPK
Related Products
|
| |
|
| MAPK Pathway
ACTIVATORS |
| |
ALX-340-029 |
Anandamide
; AEA; Arachidonyl ethanolamide |
| |
ALX-380-051 |
Anisomycin
; 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate |
| |
ALX-270-061 |
t-Butylhydroquinone
; tBHQ |
| |
ALX-303-003 |
D-erythro-Sphingosine,
N-Hexanoyl- ; N-Hexanoyl-D-erythrosphingosine; C6-Ceramide |
| |
LKT-T7033 |
Trifluoperazine |
| |
|
| MAPK
Pathway INHIBITORS |
| |
ALX-385-008 |
Apigenin ;
4',5,7-Trihydroxyflavone |
| |
ALX-270-328 |
2-(4-Chlorophenyl)-4-(fluorophenyl)-5-pyridin-4-yl-1,2-dihydropyrazol-3-one |
| |
ALX-350-290 |
Debromohymenialdisine; DBH;
4-(2-Amino-4-oxo-2-imidazolin-5-ylidene)-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one |
| |
ALX-350-289 |
10Z-Hymenialdisine |
| |
LKT-H9861 |
Hypericin |
| |
ALX-350-030 |
Hypericin (native) |
| |
ALX-350-258 |
Parthenolide
;
(1aR-[1aR*,4E,7aS*,-10aS*,-10bR*])-2,3-6,7,7a,8,10a,10b-Octahydro-1a,5-dimethyl-8-methyleneoxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one |
| |
ALX-385-023 |
PD 98,059
; 2'-Amino-3'-methoxyflavone |
| |
ALX-270-258 |
PD 169,316
; 4-(4-Fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1Himidazole |
| |
ALX-270-324 |
Raf1
Kinase Inhibitor I ; 5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone |
| |
ALX-270-259 |
SB202190 |
| |
ALX-270-268 |
SB202190 . hydrochloride |
| |
ALX-270-179 |
SB203580 |
| |
ALX-270-325 |
SB220025 |
| |
ALX-270-351 |
SB239063 |
| |
ALX-270-257 |
SC68376 |
| |
ALX-270-260 |
SKF-86002 |
| |
ALX-270-237 |
U0126 |
| |
ALX-270-336 |
ZM 336372 |
| |
|
| MAPK
Pathway ANTIBODIES |
| |
ALX-804-061 |
MAb to MAP Kinase 1/2
(activated) (12D4) |
| |
ALX-804-288 |
MAb to MAP Kinase 2 (6G11) |
| |
ALX-804-183 |
MAb to p38 (20B11) |
| |
ALX-804-184 |
MAb to p38 (Mxi2) (13D5) |
| |
ALX-804-394 |
MAb to p38 (Mxi2)
(human) (2F2) |
| |
ALX-804-222 |
MAb to p38d (5H7) |
| |
ALX-804-409 |
MAb to a-Raf (human) (4H11) |
| |
ALX-804-387 |
MAb to c-Raf
(human) (activated) (Ser621) (6B4) |
| |
ALX-804-386 |
MAb to c-Raf
(human) (PBB-1) |
| |
ALX-804-181 |
MAb to SAP Kinase 1 (8D3) |
| |
ALX-804-241 |
MAb to SAP Kinase 1 / 2
(activated) (9H8) |
| |
ALX-804-182 |
MAb to SAP Kinase 1
(activated) (10F4) |
| |
PSC-1151 |
PAb to ASK1
(human) (CT) |
| |
PSC-1150 |
PAb to MADD (CT) |
| |
|
| MAPK
Pathway ENZYMES |
| |
ALX-201-010 |
MAP Kinase 2
(activated) (rat) (recombinant) |
| |
GLO-113-01 |
Myelin Basic Protein Kinase (bovine) Assay Kit |
| |
GLO-113 |
Myelin Basic Protein Kinase-1 (bovine) |
| |
GLO-114 |
Myelin Basic Protein Kinase-2 (bovine) |
| |
ALX-201-012 |
PHAS-I
(recombinant) |
| |
GLO-115 |
c-Raf-1
(human) (recombinant) |
| |
|
| MAPK
Pathway SUBSTRATES |
| |
ALX-155-024 |
ERT Protein Kinase Substrate |
| |
ALX-155-026 |
ERT Protein Kinase Substrate Amide |
| |
ALX-168-005 |
Tyrosine Hydroxylase (24-33)
(rat) |
| MAPK
ASSAY KITS |
| |
V13-47296 |
TransAM
Kit MAPK
Family (c-Myc, MEF2, ATF-2, ELK-1, STAT) |
| |
V13-43396
|
TransAM
Kit c-Myc
|
| |
V13-44396
|
TransAM
Kit Elk-1
|
| |
V13-48120
|
FACE AKT Activated Cell-based ELISA Kit
|
| |
V13-48220
|
FACE
AKT Chemi Activated Cell-based ELISA Kit
|
| |
V13-48115
|
FACE ATF-2 Activated Cell-based ELISA Kit
|
| |
V13-48215
|
FACE ATF-2 Chemi Activated Cell-based ELISA Kit
|
| |
V13-48125 |
FACE
c-Jun(S63) Activated Cell-based ELISA Kit |
| |
V13-48225 |
FACE
c-Jun (S63) Chemi Activated Cell-based ELISA Kit |
| |
V13-48150
|
FACE
EGFR Activated Cell-based ELISA Kit
|
| |
V13-48250
|
FACE
EGFR Chemi Activated Cell-based ELISA Kit
|
| |
V13-48140
|
FACE ERK1/2
Activated Cell-based ELISA Kit
|
| |
V13-48240
|
FACE
ERK1/2 Chemi Activated Cell-based ELISA Kit
|
| |
V13-48110
|
FACE JNK Activated Cell-based ELISA Kit
|
| |
V13-48210
|
FACE
JNK Chemi Activated Cell-based ELISA Kit
|
| |
V13-48180
|
FACE MEK1/2 Activated Cell-based ELISA Kit
|
| |
V13-48280
|
FACE MEK1/2 Chemi Activated Cell-based ELISA Kit
|
| |
V13-48100
|
FACE p38 Activated Cell-based ELISA Kit
|
| |
V13-48200
|
FACE
p38 Chemi Activated Cell-based ELISA Kit
|
